Lakeview Capital Partners LLC Sells 647 Shares of Metlife Inc (NYSE:MET)

Lakeview Capital Partners LLC decreased its position in shares of Metlife Inc (NYSE:MET) by 12.4% during the 3rd quarter, Holdings Channel reports. The fund owned 4,585 shares of the financial services provider’s stock after selling 647 shares during the quarter. Lakeview Capital Partners LLC’s holdings in Metlife were worth $216,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Kavar Capital Partners LLC acquired a new stake in Metlife during the 2nd quarter worth approximately $25,000. Motco raised its holdings in shares of Metlife by 160.6% in the second quarter. Motco now owns 516 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 318 shares during the last quarter. Coastal Capital Group Inc. acquired a new stake in shares of Metlife in the second quarter valued at approximately $30,000. Venturi Wealth Management LLC acquired a new stake in shares of Metlife in the third quarter valued at approximately $37,000. Finally, Meeder Asset Management Inc. raised its holdings in shares of Metlife by 2,474.2% in the second quarter. Meeder Asset Management Inc. now owns 798 shares of the financial services provider’s stock valued at $40,000 after purchasing an additional 767 shares during the last quarter. 75.59% of the stock is currently owned by institutional investors and hedge funds.

MET traded up $0.28 during trading on Friday, reaching $49.32. 5,509,790 shares of the stock were exchanged, compared to its average volume of 5,417,675. The stock has a market cap of $45.78 billion, a P/E ratio of 9.15, a price-to-earnings-growth ratio of 1.09 and a beta of 1.12. Metlife Inc has a twelve month low of $37.76 and a twelve month high of $51.16. The stock’s 50 day moving average price is $46.53 and its two-hundred day moving average price is $47.39. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.14 and a current ratio of 0.15.

Metlife (NYSE:MET) last issued its earnings results on Wednesday, October 30th. The financial services provider reported $1.27 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.40 by ($0.13). The firm had revenue of $16.92 billion for the quarter, compared to analyst estimates of $16.37 billion. Metlife had a return on equity of 8.82% and a net margin of 10.82%. Metlife’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.38 earnings per share. Equities research analysts predict that Metlife Inc will post 5.55 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Tuesday, November 5th will be issued a dividend of $0.44 per share. The ex-dividend date of this dividend is Monday, November 4th. This represents a $1.76 dividend on an annualized basis and a yield of 3.57%. Metlife’s payout ratio is 32.65%.

A number of analysts have recently issued reports on the stock. B. Riley reiterated a “neutral” rating on shares of Metlife in a report on Tuesday, October 15th. Citigroup lowered their target price on shares of Metlife from $42.00 to $41.00 and set a “sell” rating on the stock in a report on Friday, September 13th. UBS Group boosted their target price on shares of Metlife from $46.00 to $47.00 and gave the stock a “neutral” rating in a report on Thursday, October 10th. ValuEngine upgraded shares of Metlife from a “strong sell” rating to a “sell” rating in a report on Monday, November 4th. Finally, Zacks Investment Research downgraded shares of Metlife from a “hold” rating to a “sell” rating and set a $51.00 target price on the stock. in a report on Wednesday. Three analysts have rated the stock with a sell rating, five have given a hold rating and five have assigned a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $49.51.

Metlife Company Profile

MetLife, Inc engages in the insurance, annuities, employee benefits, and asset management businesses. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short- and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and stable value products, including general and separate account guaranteed interest contracts, and private floating rate funding agreements.

See Also: What does the Producer Price Index (PPI) tell investors?

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Metlife Inc (NYSE:MET).

Institutional Ownership by Quarter for Metlife (NYSE:MET)

Receive News & Ratings for Metlife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metlife and related companies with MarketBeat.com's FREE daily email newsletter.